Advertisement
Canada markets closed

  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CAD/USD

    0.7319
    -0.0001 (-0.02%)
     

  • CRUDE OIL

    83.46
    +0.10 (+0.12%)
     

  • Bitcoin CAD

    91,020.78
    -299.99 (-0.33%)
     

  • CMC Crypto 200

    1,429.33
    +14.57 (+1.03%)
     

  • GOLD FUTURES

    2,336.60
    -5.50 (-0.23%)
     

  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • NASDAQ futures

    17,693.50
    +86.75 (+0.49%)
     

  • VOLATILITY

    15.69
    -1.25 (-7.38%)
     

  • FTSE

    8,044.81
    +20.94 (+0.26%)
     

  • NIKKEI 225

    37,552.16
    0.00 (0.00%)
     

  • CAD/EUR

    0.6836
    0.0000 (0.00%)
     

Synergy Pharmaceuticals (SGYP) Jumps: Stock Rises 7.3% - Tale of the Tape

Zacks Equity Research
Updated

Synergy Pharmaceuticals, Inc. (SGYP) was a big mover last session, as the company saw its shares rise over 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $3.42 to $4.11 in the past one-month time frame.

In the last 30 days, the company witnessed two positive estimate revisions and the Zacks Consensus Estimate also moved higher over the same time frame, suggesting that more solid trading could be ahead for Synergy Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Synergy Pharmaceuticals currently carries a Zacks Rank #2 (Buy).

A better-ranked stock in the med-drugs industry is Valeant Pharmaceuticals International, Inc. (VRX), which sports a Zacks Rank #1 (Strong Buy).

ADVERTISEMENT

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
SYNERGY PHARMAC (SGYP): Free Stock Analysis Report
 
VALEANT PHARMA (VRX): Free Stock Analysis Report
 
To read this article on Zacks.com click here.